🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a study to investigate the potential clinical benefit of trilacicl...
Status
Terminated
Location
Arizona Oncology Associates, PC - HOPE
Start Date
2017-02-02
Trial ID
NCT02978716
Treatments Being Tested
A Randomized, double-blind, placebo-controlled, multi-center Phase 3 study ...
Status
Completed
Location
Jilin Cancer Hopspital
Start Date
2021-05-25
Trial ID
NCT04902885
Treatments Being Tested
This study is a single arm, exploratory clinical study aimed at evaluating ...
Status
Enrolling By Invitation
Location
Henan Tumor Hospital
Start Date
2024-04-02
Trial ID
NCT06370416
Treatments Being Tested
To evaluate the efficacy and safety of Envafolimab Plus Docetaxel in combin...
Status
Unknown
Location
Multiple Locations
Start Date
2023-07-01
Trial ID
NCT05910034
Treatments Being Tested
The goal of this open-label randomized controlled study is to assess the my...
Status
Not Yet Recruiting
Location
Medical Oncology,Sun Yat-sen University Cancer Center
Start Date
2024-03-01
Trial ID
NCT06297811
Treatments Being Tested
Clinical data of patients with synchronous radiotherapy for esophageal canc...
Status
Recruiting
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2024-04-02
Trial ID
NCT06698692
Treatments Being Tested
This prospective, randomized, controlled phase II study aims to evaluate th...
Status
Recruiting
Location
Shanghai Chest Hospital
Start Date
2024-10-13
Trial ID
NCT06698965
Treatments Being Tested
Trilaciclib, an innovative first-in-class therapy that protects bone marrow...
Status
Recruiting
Location
The Fourth Hospital of Hebei Medical University
Start Date
2023-01-01
Trial ID
NCT07490236
Treatments Being Tested
This study is a double-arm, randomized, controlled, single-center, phase II...
Status
Recruiting
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2024-07-09
Trial ID
NCT06569459
Treatments Being Tested